Table 1.

Participant demographics and clinical summary

Participant Characteristics	Values
Sex (female/male)	4 / 9
Age (years)	62.1 ± 10.7
Time since diagnosis (years)	6.4 ± 4.5
Fluctuator (yes/no)	5 / 8
Side predominantly affected at first assessment (right/left/bilateral)	2 / 8 / 3
MDS part III score, day 1 OFF medication	28.8 ± 10.2
MDS part III score, day 1 ON medication	17.9 ± 6.8
MDS part III score, day 2 ON medication	19.6 ± 6.0

Relevant demographic characteristics of study participants included in this analysis. Values are presented as Mean ± Standard Deviation where applicable. Total participants (N) was 13.